Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
zinc + copper + selenious acid
- Development stage
- Unknown
- Lead developer
- American Regent
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
A combination of trace elements (zinc, copper, and selenious acid) used as a supplement in parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. This specific combination appears to be used in clinical trials to evaluate manganese safety in patients requiring long-term parenteral nutrition.
Beyond the preview
Go deeper on zinc + copper + selenious acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on zinc + copper + selenious acid.